—According to data from this study and previous ones, SLE develops in about 3% of children diagnosed with ITP. Can we tell which children are at risk? Share on Facebook. Opens in a new tab or window ...

Black children with systemic lupus erythematosus (SLE) are at the highest risk of adverse renal outcomes, the study found. Outcomes have improved over the past decade and a half for children with ...

The 200mg single-dose prefilled autoinjector allows pediatric patients to receive SLE treatment at home via SC administration. The Food and Drug Administration (FDA) has approved Benlysta (belimumab) ...

Several years of preliminary research results suggest chimeric antigen receptor (CAR) T-cell therapy could benefit pediatric patients with refractory systemic lupus erythematosus (SLE). When diagnosed ...

In this retrospective analysis, responses persisted with hydroxychloroquine treatment. Results of a study suggest treatment using hydroxychloroquine (HCQ) for immune thrombocytopenia (ITP) related to ...

Project Title: Does Air Pollution Influence the Baseline Characteristics of Pediatric SLE? Project Summary: Childhood-onset systemic lupus erythematosus (cSLE) is a rare and severe autoimmune disease ...

Patients with SLE are at increased risk for premature atherosclerosis. Dyslipoproteinemia, an etiologic factor, has been demonstrated in adult SLE patients, although the relationships of disease ...

The 200-mg subcutaneous injection is for children 5 years and older. HealthDay News — The US Food and Drug Administration has approved a 200 mg subcutaneous route of administration of Benlysta ...

Please provide your email address to receive an email when new articles are posted on . Patients with pediatric discoid lupus erythematosus combined with systemic lupus erythematosus were most likely ...